Reprogramming clinical outcome

Geneviève Deblois and Vincent Giguère ()
Additional contact information
Geneviève Deblois: Medicine and Oncology, McGill University, Montreal, Quebec H3A 1A3, Canada.
Vincent Giguère: Medicine and Oncology, McGill University, Montreal, Quebec H3A 1A3, Canada.

Nature, 2012, vol. 481, issue 7381, 275-276

Abstract: On binding to its target hormone, the oestrogen-receptor protein modulates the expression of many genes. Changes in the receptor's interaction with DNA have now been linked to clinical outcome in patients with breast cancer. See Letter p.389

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/481275a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:481:y:2012:i:7381:d:10.1038_481275a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/481275a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().